Kusajili – Clinical trials directory

Result of your search per sponsor: Nemanja Damjanov, MD PhD

Woman and Man Max 99 years
Nemanja Damjanov, MD PhD Update Il y a 4 ans

Single Dose PG102 in Patients With Active Psoriatic Arthritis The primary objective is to evaluate the safety and tolerability of a single intravenous dose of PG102 in patients with psoriatic arthritis. The secondary objectives are to evaluate how PG...

Country Serbia
organs None
Specialty None

Closed trial

More information